Related Patent Info

PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING

Inventor OLSON, Eric, N., etc.
Assignee THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Title of Invention PREVENTION OF MUSCULAR DYSTROPHY BY CRISPR/CAS9-MEDIATED GENE EDITING
Abstract

Provided is a method for correcting a dystrophin gene defect in a patient with Duchenne muscular dystrophy (DMD) through skipping of a mutant exon of the gene by means of CRISPR/Cas9-mediated gene editing, the method being applicable to a muscle cell, a satellite cell or an iPS cell from the DMDpatient.